Jeff Landau
2021
In 2021, Jeff Landau earned a total compensation of $1.8M as Senior Vice President and Chief Business Officer at CytomX Therapeutics.
Compensation breakdown
| Bonus | $115,000 |
|---|---|
| Non-Equity Incentive Plan | $112,688 |
| Option Awards | $1,127,559 |
| Salary | $274,924 |
| Stock Awards | $120,150 |
| Other | $5,000 |
| Total | $1,755,321 |
Landau received $1.1M in option awards, accounting for 64% of the total pay in 2021.
Landau also received $115K in bonus, $112.7K in non-equity incentive plan, $274.9K in salary, $120.2K in stock awards and $5K in other compensation.
Rankings
In 2021, Jeff Landau's compensation ranked 6,569th out of 12,415 executives tracked by ExecPay. In other words, Landau earned more than 47.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,569 out of 12,415 | 47th |
Division Manufacturing | 2,829 out of 5,508 | 49th |
Major group Chemicals And Allied Products | 1,246 out of 2,378 | 48th |
Industry group Drugs | 1,111 out of 2,099 | 47th |
Industry Pharmaceutical Preparations | 806 out of 1,549 | 48th |
Source: SEC filing on April 27, 2023.
Landau's colleagues
We found five more compensation records of executives who worked with Jeff Landau at CytomX Therapeutics in 2021.
2021
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
2021
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
2021
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
2021
Lloyd Rowland
CytomX Therapeutics
General Counsel
2021
Carlos Campoy
CytomX Therapeutics